Evidence map›Paper›PMID 38339932›Full record

ArticleJournal of Alzheimer's disease : JAD2024

Prognostic Information on Progression to Dementia: Quantification of the Impact on Quality of Life.

Robin Jeanna Vermeulen, Bram Roudijk, Tim Martin Govers, Maroeska Mariet Rovers, Marcel Gerardus Maria Olde Rikkert, Ben Franciscus Martinus Wijnen

Abstract read
In one paragraph

Article in Journal of Alzheimer's disease : JAD, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Robin Jeanna VermeulenDepartment of Medical Imaging, Radboud University Medical Centre, Nijmegen, The Netherlands.
Bram RoudijkEuroQol Research Foundation, Rotterdam, The Netherlands.
Tim Martin GoversDepartment of Medical Imaging, Radboud University Medical Centre, Nijmegen, The Netherlands.
Maroeska Mariet RoversDepartment of Medical Imaging, Radboud University Medical Centre, Nijmegen, The Netherlands.
Marcel Gerardus Maria Olde RikkertDepartment of Geriatrics, Radboudumc Alzheimer Centre, Radboud University Medical Centre, Nijmegen, The Netherlands.
Ben Franciscus Martinus WijnenCenter for Economic Evaluations, Trimbos Institute, Utrecht, The Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The increasing interest in early identification of people at risk of developing dementia, has led to the development of numerous models aimed at estimating the likelihood of progression from mild cognitive impairment (MCI) to dementia. It is important to study both the need for and possible outcomes related with such prediction models, including the impact of risk predictions on perceived quality of life (QoL). Objective: This study aimed to quantify the impact that receiving a risk prediction on progression from MCI to dementia has on QoL. Methods: A Discrete Choice Experiment (DCE) and Time Trade Off (TTO) study were performed. Participants completed choice tasks related to dementia prognosis while imagining having MCI. We collected DCE data by an online survey, and TTO data via videoconferencing interviews. DCE data were analyzed using a mixed multinomial logit model and were anchored to a health state utility scale using mean observed TTO valuations. Results: 296 people participated in the DCE and 42 in the TTO. Moderate and high predicted dementia risks were associated with decrements in utility (-0.05 and -0.18 respectively), compared to no prognostic information. Low predicted risk was associated with an increase in utility (0.06), as well as the availability of medication or lifestyle interventions (0.05 and 0.13 respectively). Conclusions: This study shows a significant impact of dementia risk predictions on QoL and highlights the importance of caution when sharing information about expected MCI disease courses.

Indexed as

Alzheimer DiseaseCognitive DysfunctionDisease ProgressionHumansPrognosisQuality of LifeAlzheimer’s diseasedementiahealth state utilitymild cognitive impairmentprognosisquality of liferisk assessment

Identifiers

PMID38339932
PMCPMC10894563

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.